Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/16/2025

Acute Ischemic Stroke Management

Initial Evaluation and Management

  • The American Heart Association recommends immediate neurological evaluation and brain imaging studies (CT or MRI) to rule out hemorrhage and determine eligibility for reperfusion therapies in patients with suspected acute ischemic stroke 1
  • A validated stroke severity scale (such as NIHSS) should be used to assess the severity of neurological deficit 1
  • Maintenance of airway, breathing, and circulation, with tracheal intubation indicated for patients with compromised airway or inadequate ventilation, is crucial 1
  • Supplemental oxygen should be provided to maintain saturation ≥94% 1

Reperfusion Therapies

  • The American College of Cardiology recommends intravenous administration of rtPA (0.9 mg/kg, maximum 90 mg) for selected patients within 4.5 hours of symptom onset 1, 2
  • Blood pressure should be <185/110 mmHg before administering rtPA 3, 2
  • The dose of rtPA for acute ischemic stroke is lower than that recommended for myocardial infarction or pulmonary embolism 3

Endovascular Therapy

  • Intra-arterial thrombolysis is an option for patients with basilar artery occlusion, even in longer time intervals (up to 6-12 hours) 4, 5
  • Case series data suggest that this approach may be beneficial in patients with basilar artery occlusion treated in longer time intervals 5
  • Treatment requires that the patient be in an experienced stroke center with immediate access to cerebral angiography and interventional neuroradiology 5

Physiological Parameter Management

  • In patients not receiving reperfusion therapies, antihypertensive treatment should be avoided unless systolic blood pressure is >220 mmHg or diastolic >120 mmHg 6, 1
  • Emergency treatment of hypertension is recommended if there is concomitant acute myocardial infarction, aortic dissection, acute renal failure, acute pulmonary edema, or preeclampsia/eclampsia 1, 2
  • Blood glucose should be monitored regularly and hyperglycemia treated to maintain levels <300 mg/dL (<16.63 mmol/L) 6, 2
  • Sources of fever should be treated and antipyretics used for elevated temperatures 2

Complication Management

  • Corticosteroids are not recommended for cerebral edema and increased intracranial pressure 1, 2
  • Osmotic therapy and hyperventilation are recommended for patients who deteriorate 1, 2
  • Surgical decompression may be necessary for large cerebellar infarcts causing brainstem compression and hydrocephalus 1, 2
  • New-onset seizures should be treated with appropriate short-acting medications (e.g., lorazepam IV) if not self-limiting 2

Rehabilitation and Supportive Care

  • Initial assessment by rehabilitation professionals should be performed within 48 hours of admission 1, 2
  • Rehabilitation therapy should begin as soon as possible once the patient is medically stable 1, 2
  • Frequent and brief out-of-bed activity involving active sitting, standing, and walking should begin within 24 hours if no contraindications exist 2

Common Errors and Precautions

  • Delays in recognition and treatment significantly worsen outcomes - every 30 minutes of delay in recanalization decreases the probability of a good functional outcome by 8-14% 2
  • Overly selective treatment criteria may exclude patients who could benefit from therapy 2
  • Inadequate control of blood pressure before thrombolysis increases the risk of hemorrhage 2
  • Failure to monitor and treat complications (swallowing difficulties, infections, venous thromboembolism) can worsen outcomes 2

Lumbar Puncture After Intravenous Thrombolysis for Ischemic Stroke

Guideline-Based Recommendations

  • The American Heart Association/American Stroke Association recommends that IV alteplase may be considered for patients who present with acute ischemic stroke, even when they may have undergone a lumbar dural puncture in the preceding 7 days (Class IIb; Level of Evidence C-EO) 7

Key Safety Considerations

  • Increased risk of bleeding complications is present when lumbar puncture is performed within the first 24 hours after thrombolysis 7
  • The safest approach is to delay lumbar puncture until at least 24 hours after thrombolysis administration, when the fibrinolytic effects have substantially diminished 7

Clinical Decision Algorithm

  • If cerebrospinal fluid analysis is critical for diagnosis, ensure platelet count >50,000/μL and INR <1.7 before proceeding with lumbar puncture 7
  • Monitor neurologically every 15 minutes for first 2 hours, then hourly for 24 hours after lumbar puncture 7

Evidence Quality and Limitations

  • The evidence supporting LP after thrombolysis is limited to expert opinion (Class IIb, Level C-EO), reflecting the lack of controlled trials 7

Common Pitfalls to Avoid

  • Do not perform routine LP within 24 hours of thrombolysis unless absolutely necessary for life-threatening diagnosis 7
  • Do not proceed with lumbar puncture without ensuring adequate platelet count and coagulation parameters 7
  • Do not fail to establish rigorous neurological monitoring protocol post-procedure 7

Acute Ischemic Stroke Management

Reperfusion Therapy

  • For patients with acute ischemic stroke presenting within 3 hours of symptom onset, the American College of Chest Physicians recommends administering intravenous alteplase (0.9 mg/kg, maximum 90 mg) immediately after excluding hemorrhage on CT scan, with a strong recommendation (Grade 1A) 8
  • The American College of Chest Physicians suggests IV alteplase for patients presenting 3-4.5 hours from onset, but with weaker evidence (Grade 2C), and notes that clinical trial data demonstrates significant improvement in functional outcomes despite increased symptomatic hemorrhage risk 8
  • For large vessel occlusions, the American College of Cardiology recommends combined stent-retriever and aspiration techniques to achieve fast first-pass complete reperfusion 9
  • Every 30-minute delay in recanalization decreases the probability of good functional outcome by 8-14%, according to the American College of Cardiology 10

Antiplatelet Therapy

  • The American College of Chest Physicians recommends initiating aspirin 160-325 mg within 48 hours of symptom onset for all patients not receiving thrombolysis, with a strong preference (Grade 1A) over therapeutic anticoagulation in the acute phase 8

Venous Thromboembolism Prophylaxis

  • The American College of Chest Physicians recommends initiating prophylactic-dose LMWH (preferred over UFH) or applying intermittent pneumatic compression devices within 24 hours for patients with restricted mobility after ischemic stroke 8
  • The American College of Chest Physicians advises against using elastic compression stockings alone for VTE prophylaxis (Grade 2B) 8

Long-Term Secondary Prevention

  • For long-term prevention after non-cardioembolic ischemic stroke, the American College of Chest Physicians recommends prescribing clopidogrel 75 mg daily OR aspirin/extended-release dipyridamole 25/200 mg twice daily as first-line agents, with a preference over aspirin alone (Grade 2B) 8
  • The American College of Chest Physicians advises against using combination clopidogrel plus aspirin long-term (Grade 1B) 8

Critical Pitfalls to Avoid

  • The American College of Cardiology notes that time delays are devastating, with every 30-minute delay reducing good outcomes by 8-14%, and recommends streamlining imaging and avoiding time-consuming protocols 10
  • The American College of Cardiology advises against overly restrictive selection criteria, recommending a focus on who should NOT be treated rather than narrow eligibility 10
  • The American College of Chest Physicians advises against using elastic stockings alone for VTE prophylaxis, as they are ineffective in stroke patients (Grade 2B) 8

REFERENCES

1

Acute Ischemic Stroke Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Acute Stroke Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025